HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS:DATA FROM THE EUROSPA COLLABORATION

Details

Database :

OAIster

Journal :

Michelsen , B , Ørnbjerg , L , Loft , A G , Sexton , J , Ciurea , A , Mann , H , Eklund , K , Yazici , A , Santos , M J , Askling , J , Rotar , Z , Gudbjornsson , B , Pombo-suarez , M , Codreanu , C , Horst-bruinsma , I V D , Kristianslund , E , Nissen , M , Pavelka , K , Trokovic , N , Inanc , N , Vieira-sousa , E , Giuseppe , D D , Tomsic , M , Geirsson , A J , Ionescu , R , Sande , M V D , Iannone , F , Sánchez-piedra , C , Jones , G T , Hyldstrup , L , Krogh , N S , Hetland , M L & Østergaard , M 2019 , ' HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS : DATA FROM THE EUROSPA COLLABORATION ' , Annals of the Rheumatic Diseases , vol. 78 , no. Suppl 2 , FRI0403 , pp. 887-888 .

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1322741050

Document Type :

Electronic Resource